[Preliminary evaluation of the toxicity of C-283 compound used intravenously].
D000166:Acridines / Q000008:administration & dosage / Q000009:adverse effects*; D000368:Aged; D000970:Antineoplastic Agents / Q000009:adverse effects*; D006801:Humans; D007275:Injections, Intravenous; D007668:Kidney / Q000187:drug effects; D008099:Liver / Q000187:drug effects; D008875:Middle Aged; D009369:Neoplasms / Q000188:drug therapy; D009574:Nitro Compounds / Q000008:administration & dosage / Q000009:adverse effects; D010689:Phlebitis / Q000139:chemically induced; D011437:Propylamines / Q000008:administration & dosage / Q000009:adverse effects
D000166:Acridines; D000970:Antineoplastic Agents; D009574:Nitro Compounds; D011437:Propylamines
Wstepna ocena toksyczności swiazku C-283 stosowanego dozylnie.